Cynosure (CYNO) 10-Q 7 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'CYNO	'
Entity Registrant Name	'CYNOSURE INC	'
Entity Central Index Key	'0000885306	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	21,648,006

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$53,754	$93,655
Short-term marketable securities	34,171	26,633
Accounts receivable, net	44,121	36,587
Inventories	59,034	50,251
Prepaid expenses and other current assets	12,201	6,891
Deferred income taxes	9,475	9,341
Total current assets	212,756	223,358
Property and equipment, net	35,039	26,445
Long-term marketable securities	25,071	8,804
Goodwill	105,115	99,237
Intangibles, net	55,863	55,179
Other assets	1,829	1,678
Total assets	435,673	414,701
Current liabilities:	'	'
Accounts payable	20,960	13,985
Amounts due to related party	'	1,268
Accrued expenses	36,501	36,954
Deferred revenue	9,621	9,163
Capital lease obligation	171	286
Total current liabilities	67,253	61,656
Capital lease obligation, net of current portion	15,689	14,957
Deferred revenue, net of current portion	818	1,010
Other noncurrent liability	16,058	8,726
Commitments and contingencies	'	'
Stockholders' equity:	'	'
Preferred stock, $0.001 par value Authorized - 5,000 shares Issued - none	'	'
Class A and Class B common stock, $0.001 par value Authorized - 70,000 shares Issued - 23,203 Class A shares and no Class B shares at September 30, 2014 Issued - 22,633 Class A shares and no Class B shares at December 31, 2013	23	23
Additional paid-in capital	354,726	338,742
Retained earnings	16,974	8,636
Accumulated other comprehensive loss	-2,764	-1,499
Treasury stock, 1,629 Class A shares, at cost, at September 30, 2014; 886 Class A shares, at cost, at December 31, 2013	-33,104	-17,550
Total stockholders' equity	335,855	328,352
Total liabilities and stockholders' equity	$435,673	$414,701

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Class A and Class B common stock, shares authorized	70,000,000	70,000,000
Common Stock Class A [Member]	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares issued	23,203,000	22,633,000
Treasury stock, shares	1,629,000	886,000
Common Stock Class B [Member]	'	'
Common stock, par value	$0.00	$0.00
Common stock, shares issued	0	0

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
Product revenues	$55,672	$50,147	$164,969	$127,286
Parts, accessories, service and royalties revenues	15,858	10,545	41,138	24,187
Total revenues	71,530	60,692	206,107	151,473
Cost of revenues	31,232	26,558	89,721	65,865
Gross profit	40,298	34,134	116,386	85,608
Operating expenses:	'	'	'	'
Sales and marketing	21,721	17,364	62,710	44,198
Research and development	5,746	5,033	16,319	12,350
Amortization of intangible assets acquired	740	451	2,166	948
General and administrative	6,841	12,712	22,197	42,189
Total operating expenses	35,048	35,560	103,392	99,685
Income (loss) from operations	5,250	-1,426	12,994	-14,077
Interest (expense) income, net	-342	25	-1,034	80
Other (expense) income, net	-827	721	-548	318
Income (loss) before provision for income taxes	4,081	-680	11,412	-13,679
Provision (benefit) for income taxes	1,007	601	3,074	-4,683
Net income (loss)	$3,074	($1,281)	$8,338	($8,996)
Basic net income (loss) per share	$0.14	($0.06)	$0.38	($0.49)
Diluted net income (loss) per share	$0.14	($0.06)	$0.37	($0.49)
Basic weighted-average common shares outstanding	21,637	22,331	21,900	18,406
Diluted weighted-average common shares outstanding	21,900	22,331	22,280	18,406

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Loss) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Statement of Comprehensive Income [Abstract]	'	'	'	'
Net income (loss)	$3,074	($1,281)	$8,338	($8,996)
Other comprehensive (loss) income components:	'	'	'	'
Cumulative translation adjustment	-1,429	713	-1,249	85
Unrealized (loss) gain on marketable securities	-12	11	-16	32
Total other comprehensive (loss) income	-1,441	724	-1,265	117
Comprehensive income (loss)	$1,633	($557)	$7,073	($8,879)

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Operating activities:	'	'
Net income (loss)	$8,338	($8,996)
Reconciliation of net income (loss) to net cash provided by (used in) operating activities:	'	'
Depreciation and amortization	13,100	6,579
Impairment loss on assets held for sale	'	468
Stock-based compensation expense	5,320	2,570
Loss on disposal of fixed assets	67	105
Noncash interest expense on capital lease obligations	1,110	'
Deferred income taxes	-127	-5,641
Net accretion of marketable securities	1,134	1,300
Changes in operating assets and liabilities:	'	'
Accounts receivable	-5,994	-13,149
Inventories	-6,325	-4,381
Net book value of demonstration inventory sold	500	465
Prepaid expenses and other current assets	759	970
Accounts payable	5,774	-2,850
Due to related party	'	-621
Tax benefit from stock option exercises	-3,033	-39
Accrued expenses	-2,599	5,799
Deferred revenue	-63	2,364
Other noncurrent liability	'	-109
Net cash provided by (used in) operating activities	17,961	-15,166
Investing activities:	'	'
Purchases of property and equipment	-14,011	-2,202
Proceeds from the sales and maturities of marketable securities	25,755	75,562
Purchases of marketable securities	-50,712	-10,961
Cash paid for acquisitions, net of cash received	-13,235	-64,978
Increase in other noncurrent assets	-89	-64
Net cash used in investing activities	-52,292	-2,643
Financing activities:	'	'
Excess tax benefit on options exercised	3,033	39
Repurchases of common stock	-15,554	'
Proceeds from stock option exercises	7,629	2,613
Acquisition-related equity issuance costs	'	-568
Payments on capital lease obligation	-602	-230
Net cash (used in) provided by financing activities	-5,494	1,854
Effect of exchange rate changes on cash and cash equivalents	-76	-1
Net decrease in cash and cash equivalents	-39,901	-15,956
Cash and cash equivalents, beginning of the period	93,655	86,057
Cash and cash equivalents, end of the period	53,754	70,101
Supplemental cash flow information	'	'
Cash paid for interest	14	20
Cash paid for income taxes	1,827	791
Supplemental noncash investing and financing activities	'	'
Transfer of demonstration equipment from inventory to fixed assets	3,151	5,325
Transfer of long-lived assets held for sale from fixed assets to long-lived assets held for sale	'	26,396
Assets acquired under capital lease	$166	$82

Interim_Consolidated_Financial

Interim Consolidated Financial Statements	9 Months Ended
	Sep. 30, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Interim Consolidated Financial Statements	'
	Note 1   Interim Consolidated Financial Statements
	The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP) for interim information and pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) for reporting on Form 10-Q. Accordingly, certain information and footnote disclosures required for complete financial statements are not included herein. It is recommended that these financial statements be read in conjunction with the consolidated financial statements and related notes that appear in the Annual Report on Form 10-K of Cynosure, Inc. (Cynosure) for the year ended December 31, 2013. The December 31, 2013 consolidated balance sheet within this Quarterly Report on Form 10-Q has been recast to reflect updated purchase accounting adjustments associated with the 2013 acquisition of Palomar Medical Technologies, Inc. (Palomar). In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation of the financial position, results of operations, and cash flows as of the dates and for the periods presented have been included. The results of operations for the three and nine months ended September 30, 2014 may not be indicative of the results that may be expected for the year ending December 31, 2014, or any other period.

StockBased_Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock-Based Compensation	'
	Note 2   Stock-Based Compensation
	Cynosure recorded stock-based compensation expense of $2.0 million and $0.9 million for the three months ended September 30, 2014 and 2013, respectively. Cynosure recorded stock-based compensation expense of $5.3 million and $2.6 million for the nine months ended September 30, 2014 and 2013, respectively. As of September 30, 2014 and 2013, respectively, Cynosure had $25,000 and $20,000 of stock-based compensation expense capitalized as a part of inventory.
	Total stock-based compensation expense was recorded to cost of revenues and operating expenses based upon the functional responsibilities of the individual holding the respective share-based payments, as follows:
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014		2013
		(In thousands)
	Cost of revenues	$	79		$	44	$	219	$	121
	Sales and marketing		519			260		1,481		761
	Research and development		270			133		757		424
	General and administrative		1,108			430		2,863		1,264
	Total stock-based compensation expense	$	1,976		$	867	$	5,320	$	2,570
	Cash received from option exercises was $7.6 million and $2.6 million during the nine months ended September 30, 2014 and 2013, respectively.
	Cynosure granted 849,680 and 386,010 stock options during the nine months ended September 30, 2014 and 2013, respectively. Cynosure has elected to use the Black-Scholes model to determine the weighted average fair value of options. The weighted average fair value of the options granted during the nine months ended September 30, 2014 and 2013 was $10.51 and $13.10, respectively, using the following assumptions:
		Nine Months Ended September 30,
		2014		2013
	Risk-free interest rate	1.44% - 1.80%		0.79% - 1.49%
	Expected dividend yield
	Expected term	4.6 years		4.8 years
	Expected volatility	43% - 44%		54% - 56%
	Estimated forfeiture rate	5%		5%
	Option-pricing models require the input of various subjective assumptions, including the option’s expected life and the price volatility of the underlying stock. Cynosure’s estimated expected stock price volatility is based on its own historical volatility. Cynosure’s expected term of options represents the weighted average period of time that options granted are expected to be outstanding giving consideration to vesting schedules and Cynosure’s historical exercise patterns. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The dividend yield of zero is based on the fact that Cynosure has never paid cash dividends and has no present intention to pay cash dividends.
	Cynosure granted 44,840 restricted stock units (RSUs) during the nine months ended September 30, 2014 to employees at a fair market value of its common stock on the date of grant and which vest quarterly over a three-year period. Cynosure is recognizing related compensation expense on a straight-line basis over the three-year period.
	Cynosure granted 43,500 RSUs during the nine months ended September 30, 2014 to non-employee directors at a fair market value of its common stock on the date of grant and which vest quarterly over a one-year period. Cynosure is recognizing related compensation expense on a straight-line basis over the one-year period.

Inventories

Inventories	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	Note 3   Inventories
	Cynosure states all inventories at the lower of cost or market, determined on a first-in, first-out method. Inventory includes material, labor and overhead and consists of the following:
		September 30,		December 31,
		2014		2013 (recast)
		(in thousands)
	Raw materials	$	15,158	$	16,900
	Work in process		3,886		2,316
	Finished goods		39,990		31,035
		$	59,034	$	50,251

Fair_Value

Fair Value	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Fair Value	'
	Note 4   Fair Value
	U.S. GAAP establishes a framework for measuring fair value under generally accepted accounting principles and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes the following fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, that may be used to measure fair value:
		•		Level 1   Quoted prices in active markets for identical assets or liabilities.
		•		Level 2   Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable markets data for substantially the full term of the assets or liabilities.
		•		Level 3   Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
	The following table represents Cynosure’s fair value hierarchy for its financial assets (cash equivalents and marketable securities) measured at fair value as of September 30, 2014 (in thousands):
			Level 1		Level 2		Level 3	Total
	Money market funds (1)		$	887	$		$	$	887
	State and municipal bonds					48,720			48,720
	Treasuries and government agencies					8,498			8,498
	Corporate obligations and commercial paper					2,007			2,007
	Equity securities			17					17
	Total		$	904	$	59,225	$	$	60,129
	-1	Included in cash and cash equivalents at September 30, 2014.
	During the nine months ended September 30, 2014, there were no significant transfers in and out of Level 1 and Level 2. Cynosure did not have any Level 3 financial assets at September 30, 2014 or December 31, 2013.

Short_and_LongTerm_Marketable_

Short and Long-Term Marketable Securities	9 Months Ended
	Sep. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
Short and Long-Term Marketable Securities	'
	Note 5   Short and Long-Term Marketable Securities
	Cynosure’s available-for-sale securities at September 30, 2014 consist of approximately $59.2 million of investments in debt securities consisting of state and municipal bonds, treasuries and government agencies, corporate obligations and commercial paper and approximately $17,000 in equity securities. All investments in available-for-sale securities are recorded at fair market value, with any unrealized gains and losses reported as a separate component of accumulated other comprehensive loss. As of September 30, 2014, Cynosure’s marketable securities consist of the following (in thousands):
		Market		Amortized		Unrealized		Unrealized
		Value		Cost		Gains		Losses
	Available-for-Sale Securities:
	Short-term marketable securities:
	State and municipal bonds	$	26,145	$	26,129	$	16	$
	Treasuries and government agencies		6,002		6,001		1
	Corporate obligations and commercial paper		2,007		2,005		2
	Equity securities		17		22				(5	)
	Total short-term marketable securities	$	34,171	$	34,157	$	19	$	(5	)
	Long-term marketable securities:
	State and municipal bonds	$	22,575	$	22,569	$	11	$	(5	)
	Treasuries and government agencies		2,496		2,500				(4	)
	Total long-term marketable securities	$	25,071	$	25,069	$	11	$	(9	)
	Total available-for-sale securities	$	59,242	$	59,226	$	30	$	(14	)
	Total marketable securities	$	59,242
	As of December 31, 2013, Cynosure’s marketable securities consist of the following (in thousands):
		Market		Amortized		Unrealized		Unrealized
		Value		Cost		Gains		Losses
	Available-for-Sale Securities:
	Cash equivalents:
	State and municipal bonds	$	793	$	793	$		$
	Total cash equivalents	$	793	$	793	$		$
	Short-term marketable securities:
	State and municipal bonds	$	10,552	$	10,551	$	1	$
	Treasuries and government agencies		15,028		15,018		10
	Corporate obligations and commercial paper		1,004		1,004
	Equity securities		49		8		41
	Total short-term marketable securities	$	26,633	$	26,581	$	52	$
	Long-term marketable securities:
	State and municipal bonds	$	6,788	$	6,787	$	1	$
	Corporate obligations and commercial paper		2,016		2,015		1
	Total long-term marketable securities	$	8,804	$	8,802	$	2	$
	Total available-for-sale securities	$	36,230	$	36,176	$	54	$
	Total marketable securities	$	35,437
	As of September 30, 2014, Cynosure’s available-for-sale debt securities mature as follows (in thousands):
		Total		Maturities
				Less		One to		More
				Than		Five		than
				One		Years		Five
				Year				Years
	State and municipal bonds	$	48,720	$	26,145	$	22,575	$
	Treasuries and government agencies		8,498		6,002		2,496
	Corporate obligations and commercial paper		2,007		2,007
	Total available-for-sale debt securities	$	59,225	$	34,154	$	25,071	$

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Acquisitions	'
	Note 6   Acquisitions
	Ellman International, Inc.
	On September 5, 2014, Cynosure acquired substantially all of the assets of Ellman International, Inc. (Ellman) for $13.2 million in cash. In addition, Cynosure assumed current liabilities associated with normal working capital and certain contractual liabilities. The purchase price was based primarily on the net working capital on the date of purchase plus an amount to retire all of Ellman’s long term debt on the date of sale. Cynosure also assumed a license transfer agreement as part of the purchase valued at $4.2 million. The acquisition complements Cynosure’s aesthetic treatment platform with radiofrequency energy sources and accessory products. The acquisition of Ellman was considered a business acquisition for accounting purposes.
	Cynosure has retained an independent valuation firm to assess the fair value of the assets acquired and liabilities assumed. Pro forma financial information was filed with the SEC within the applicable time period. Cynosure has preliminarily allocated the purchase price to the net tangible and intangible assets based on their estimated fair values as of September 5, 2014. As such, the fair value of the assets acquired and liabilities assumed, including intangible assets, presented in the table below are provisional and will be finalized in a later period once the fair value procedures are completed. Goodwill represents the excess of purchase price over the fair value of the net assets acquired.
	The following table summarizes the estimated fair value as of September 5, 2014 of the net assets acquired (in thousands):
	Purchase price:
	Cash paid	$	13,235
	Total	$	13,235
	Assets (liabilities) acquired:
	Accounts receivable		2,147
	Inventory		4,419
	Prepaids and other assets		488
	Property and equipment		576
	Intangible assets		6,800
	Goodwill		5,886
	Accounts payable		(9	)
	Accrued expenses		(2,452	)
	Deferred revenue		(460	)
	Other noncurrent liability		(4,160	)
	Total	$	13,235
	Revenue related to Ellman’s operations was $2.6 million for the period following the September 5, 2014 acquisition date, and is included in Cynosure’s consolidated statements of operations for the three and nine months ended September 30, 2014. As a result of the integration of the operations of Ellman into Cynosure’s operations, disclosures of earnings included in the accompanying consolidated statement of operations since the acquisition date is not practicable.
	The following unaudited pro forma condensed consolidated operating results for the three and nine months ended September 30, 2014 and 2013 summarize the combined results of operations for Cynosure and Ellman. The unaudited pro forma condensed consolidated operating results includes the business combination accounting effects as if the acquisition had been completed as of January 1, 2013 (for both the 2014 and 2013 period results) after giving effect to certain adjustments. These pro forma financial statements are for informational purposes only and are not necessarily indicative of the operating results that would have occurred if the transaction had occurred on such date. No effect has been given for synergies, if any, that may be realized through the acquisition.
	Three Months Ended						Nine Months Ended
	September 30,						September 30,
		2014			2013			2014		2013
		(In thousands)
	Revenue (unaudited)	$	75,433		$	66,868		$	222,746	$	171,019
	Pre-tax income (loss) (unaudited)	$	4,027		$	(1,428	)	$	10,326	$	(15,735	)
	The unaudited consolidated pro forma financial information above includes significant, non-recurring adjustments made to account for certain costs which would have been incurred if the acquisition had been completed on January 1, 2013, including $0.3 million associated with the step up in fair value of finished goods inventory acquired through the acquisition.
	Palomar Medical Technologies, Inc.
	On June 24, 2013, Cynosure acquired Palomar. Certain adjustments related to Palomar’s opening balance sheet were finalized during the first half of 2014, after the December 31, 2013 financial statements were issued. The adjustments were based on facts that existed at the acquisition date and were finalized using information that came available during the first half of 2014. Under Accounting Standards Codification (ASC) 805, Business Combinations, an acquirer is required to recognize adjustments to provisional amounts during the measurement period as they are identified, and to recognize such adjustments retrospectively as if the accounting from the business combination had been completed at the acquisition date. As a result, the carrying amount of inventory acquired in the acquisition of Palomar was retrospectively decreased by $3.8 million on June 24, 2013, and the carrying amounts of the deferred tax liability and accounts payable acquired in the acquisition of Palomar were retrospectively increased by $0.2 million and $0.1 million, respectively, on June 24, 2013, with corresponding increases to goodwill. The carrying amount of accrued expenses acquired in the acquisition of Palomar was retrospectively decreased by $23,000 on June 24, 2013, with a corresponding decrease to goodwill. The December 31, 2013 consolidated balance sheet within this Quarterly Report on Form 10-Q has been updated to disclose these recast values.

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill	'
	Note 7   Goodwill
	Changes to goodwill during the nine months ended September 30, 2014 were as follows (in thousands):
	Balance   December 31, 2013 (recast)	$	99,237
	Ellman acquisition		5,886
	Translation adjustment		(8	)
	Balance   September 30, 2014	$	105,115

Other_Intangible_Assets

Other Intangible Assets	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Other Intangible Assets	'
	Note 8   Other Intangible Assets
	Other intangible assets consist of the following at September 30, 2014 and December 31, 2013 (in thousands):
		Developed			Business			Customer			Trade			Other			Total
		Technology			Licenses			Relationships			Names
		& Patents
	September 30, 2014
	Cost	$	29,240		$	384		$	19,718		$	18,390		$	1,338		$	69,070
	Translation adjustment					41			5						3			49
	Accumulated amortization		(6,370	)		(255	)		(5,244	)		(1,379	)		(8	)		(13,256	)
	Balance, September 30, 2014	$	22,870		$	170		$	14,479		$	17,011		$	1,333		$	55,863
	December 31, 2013
	Cost	$	27,510		$	384		$	15,833		$	16,930		$	1,338		$	61,995
	Translation adjustment					40			26						4			70
	Accumulated amortization		(2,216	)		(239	)		(3,662	)		(761	)		(8	)		(6,886	)
	Balance, December 31, 2013	$	25,294		$	185		$	12,197		$	16,169		$	1,334		$	55,179
	Cynosure acquired $6.8 million of identifiable intangible assets in the Ellman acquisition, of which $1.7 million was assigned to technology patents, $3.6 million was assigned to customer relationships and $1.5 million was assigned to trademarks. The technology patents are being amortized on an economic patterned basis over a 7.0 year weighted-average amortization period and the customer relationships and trademarks are being amortized on a straight-line basis over a 15.0 year weighted-average amortization period. In total, the weighted-average amortization period for these intangible assets is 13.0 years.
	Cynosure is currently evaluating the fair value of assets acquired and liabilities assumed from the Ellman acquisition, including identifiable intangible assets and their related amortization periods. As such, the $6.8 million in intangible assets presented in the table above is provisional and will be finalized in a later period once the fair value procedures are completed.
	Amortization expense related to developed technology and patents is classified as a component of cost of revenues. Amortization expense related to customer relationships and trade names is classified as a component of amortization of intangible assets acquired. Amortization expense related to business licenses and other is classified as a component of general and administrative expenses. For the three and nine months ended September 30, 2014, Cynosure recognized $27,000 in amortization expense, classified as a component of amortization of intangible assets acquired, related to the identifiable intangible assets from the Ellman acquisition. For the three and nine months ended September 30, 2014, Cynosure recognized $32,000 in amortization expense, classified as a component of cost of revenues, related to the identifiable intangible assets from the Ellman acquisition.
	Amortization expense for the three months ended September 30, 2014 and 2013 was $2.2 million and $1.4 million, respectively. Amortization expense for the nine months ended September 30, 2014 and 2013 was $6.4 million and $2.1 million, respectively. Cynosure has approximately $1.3 million of indefinite-life intangible assets that are included in other intangible assets in the table above. As of September 30, 2014, amortization expense on existing intangible assets for the next five years and beyond is as follows (in thousands):
	Remainder of 2014	$	2,282
	2015		9,156
	2016		8,365
	2017		6,376
	2018		4,860
	2019 and thereafter		23,494
	Total	$	54,533

Warranty_Costs

Warranty Costs	9 Months Ended
	Sep. 30, 2014
Guarantees [Abstract]	'
Warranty Costs	'
	Note 9   Warranty Costs
	Cynosure typically provides a one-year parts and labor warranty on end-user sales of lasers. Distributor sales generally include a one-year warranty on parts only. Estimated future costs for initial product warranties are provided for at the time of revenue recognition. The following table provides the detail of the change in Cynosure’s product warranty accrual during the nine months ended September 30, 2014, which is a component of accrued expenses in the consolidated balance sheets (in thousands):
	Balance   December 31, 2013	$	6,651
	Warranty provision related to new sales		10,484
	Costs incurred		(9,979	)
	Balance   September 30, 2014	$	7,156

Segment_Information

Segment Information	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Segment Information	'
	Note 10   Segment Information
	In accordance with ASC 280, Segment Reporting Topic, operating segments are identified as components of an enterprise about which separate discrete financial information is available for evaluation by the chief operating decision maker, or decision-making group, in making decisions how to allocate resources and assess performance. Cynosure’s chief decision-maker, as defined under ASC 280, is a combination of the Chief Executive Officer and the Chief Financial Officer. Cynosure views its operations and manages its business as one segment, aesthetic treatment products and services.
	The following table represents total revenue by geographic destination:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014		2013
		(in thousands)
	United States	$	39,734		$	30,906		$	100,404	$	71,340
	Europe		10,207			10,013			35,830		26,786
	Asia / Pacific		15,131			13,570			47,857		37,300
	Other		6,458			6,203			22,016		16,047
	Total	$	71,530		$	60,692		$	206,107	$	151,473
	Total assets by geographic area are as follows:
		September 30,			December 31,
		2014			2013
		(in thousands)
	United States	$	400,149		$	380,383
	Europe		23,017			21,741
	Asia / Pacific		17,889			16,437
	Eliminations		(5,382	)		(3,860	)
	Total	$	435,673		$	414,701
	Long-lived assets by geographic area are as follows:
		September 30,			December 31,
		2014			2013
		(in thousands)
	United States	$	32,353		$	24,120
	Europe		2,259			2,403
	Asia / Pacific		2,256			1,600
	Total	$	36,868		$	28,123
	No individual country within Europe or Asia/Pacific represented greater than 10% of total revenue, total assets or total long-lived assets for any period presented.
	The increase in the amount of total assets is due primarily to the Ellman acquisition. The increase in the amount of long-lived assets is primarily due to the tangible net assets acquired from the Ellman acquisition. Cynosure is currently evaluating the fair value of assets acquired and liabilities assumed.

Net_Income_Loss_Per_Common_Sha

Net Income (Loss) Per Common Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Net Income (Loss) Per Common Share	'
	Note 11   Net Income (Loss) Per Common Share
	Basic net income (loss) per share is determined by dividing net income (loss) by the weighted average common shares outstanding during the period. Diluted net income (loss) per share is determined by dividing net income (loss) by the diluted weighted average shares outstanding during the period. Diluted weighted average shares reflect the dilutive effect, if any, of common stock options and RSUs based on the treasury stock method. For the three and nine months ended September 30, 2014 and 2013, there were no outstanding Class B shares, and Cynosure may not issue Class B shares in the future.
	A reconciliation of basic and diluted shares is as follows (in thousands, except per share data):
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014		2013			2014		2013
	Net income (loss)	$	3,074	$	(1,281	)	$	8,338	$	(8,996	)
	Basic weighted average common shares outstanding		21,637		22,331			21,900		18,406
	Weighted average common equivalent shares		263					380
	Diluted weighted average common shares outstanding		21,900		22,331			22,280		18,406
	Basic net income (loss) per share	$	0.14	$	(0.06	)	$	0.38	$	(0.49	)
	Diluted net income (loss) per share	$	0.14	$	(0.06	)	$	0.37	$	(0.49	)
	For the three and nine months ended September 30, 2014, approximately 1.7 million and 1.5 million, respectively, weighted average stock options and RSUs to purchase shares of the Company’s Class A common stock were excluded from the calculation of diluted weighted average common shares outstanding as their effect was antidilutive.
	For the three and nine months ended September 30, 2013, the number of basic and diluted weighted average shares outstanding was the same, as any increase in the number of shares of common stock equivalents for the three and nine months ended September 30, 2013 would be antidilutive based on the net loss for the periods. For the three and nine months ended September 30, 2013, respectively, outstanding options to purchase 1.0 million and 1.1 million shares were excluded from the computation of diluted earnings per share because their inclusion would have been antidilutive.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Accumulated Other Comprehensive Loss	'
	Note 12   Accumulated Other Comprehensive Loss
	Changes to accumulated other comprehensive loss during the nine months ended September 30, 2014 were as follows (in thousands):
		Unrealized			Translation			Accumulated
		Gain on			Adjustment			Other
		Marketable						Comprehensive
		Securities, net						Loss
		of taxes
	Balance   December 31, 2013	$	36		$	(1,535	)	$	(1,499	)
	Current period other comprehensive loss		(16	)		(1,249	)		(1,265	)
	Balance   September 30, 2014	$	20		$	(2,784	)	$	(2,764	)

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 13   Income Taxes
	During the three months ended September 30, 2014 and 2013, Cynosure recorded an income tax provision of $1.0 million and $0.6 million, respectively, representing an effective tax rate of 25% and (88)%, respectively. The income tax provisions for the three months ended September 30, 2014 and 2013 are primarily attributable to the tax provision on the earnings of its foreign and domestic operations.
	At December 31, 2013, Cynosure had gross unrecognized tax benefits of $1.7 million, of which $0.1 million, if recognized, would favorably impact the effective tax rate. During the nine months ended September 30, 2014, unrecognized tax benefits decreased by $0.8 million, of which none impacted the effective rate. The decrease of $0.8 million in the Company’s unrecognized tax benefits resulted from management’s finalization of its assessment of pre-existing Palomar uncertain tax positions within the purchase accounting period during the second quarter of 2014. At September 30, 2013, Cynosure had gross unrecognized tax benefits of $0.9 million, of which $0.1 million, if recognized, would favorably impact the effective tax rate. During the nine months ended September 30, 2014, the amount of interest and penalties recorded on unrecognized tax benefits was immaterial. Cynosure classifies interest and penalties related to income taxes as a component of its provision for income taxes. Cynosure does not expect any material changes in the amounts of unrecognized tax benefits over the next 12 months.
	Cynosure files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions. Cynosure is no longer subject to U.S. federal income tax examinations by tax authorities for years before 2011. With few exceptions, Cynosure is no longer subject to U.S. state tax examinations for years before 2009. Additionally, certain non-U.S. jurisdictions are no longer subject to income tax examinations by tax authorities for years before 2009.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Note 14   Commitments and Contingencies
	Lease Commitments
	Cynosure leases the land portion of its U.S. operating facility and certain foreign facilities under non-cancelable operating lease agreements expiring through May 2027. These leases are non-cancellable and typically contain renewal options. Certain leases contain rent escalation clauses for which Cynosure recognizes the expense on a straight-line basis. Rent expense for the three and nine months ended September 30, 2014 was approximately $0.6 million and $2.5 million, respectively.
	Cynosure leases the buildings portion of its U.S. operating facility and certain equipment and vehicles under capital lease agreements with payments due through May 2027. Commitments under Cynosure’s lease arrangements are as follows (in thousands):
		Operating		Capital
		Leases		Leases
	Remainder of 2014	$	420	$	73
	2015		1,292		146
	2016		1,396		2,165
	2017		1,418		2,550
	2018		1,369		2,515
	2019 and thereafter		3,726		22,680
	Total minimum lease payments	$	9,621	$	30,129
	Less amount representing interest				(14,269	)
	Present value of obligations under capital leases			$	15,860
	Current portion of capital lease obligations				171
	Capital lease obligations, net of current portion			$	15,689
	Contractual Obligations
	Cynosure’s significant outstanding contractual obligations relate to its capital leases from its facilities leases, including the buildings portion of its U.S. operating facility, and equipment financings. Cynosure’s leases are non-cancellable and typically contain renewal options. Certain leases contain rent escalation clauses for which Cynosure recognizes the expense on a straight-line basis. Cynosure has summarized in the table below its fixed contractual cash obligations as of September 30, 2014.
		Total		Less Than			One to		Three to		More than
				One Year			Three Years		Five Years		Five Years
		(In thousands)
	Capital lease obligations, including interest	$	30,129	$	183		$	4,114	$	5,036	$	20,796
	Operating leases		9,621		1,389			2,782		2,064		3,386
	Total contractual obligations	$	39,750	$	1,572		$	6,896	$	7,100	$	24,182

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2014
Accounting Changes and Error Corrections [Abstract]	'
Recent Accounting Pronouncements	'
	Note 15   Recent Accounting Pronouncements
	In May 2014, the FASB issued guidance codified in ASC 606, Revenue Recognition  Revenue from Contracts with Customers, which amends the guidance in ASC 605, Revenue Recognition. This new revenue standard creates a single source of revenue guidance for all companies in all industries and is more principles-based than the current revenue guidance. The new guidance must be adopted using either a full retrospective approach for all periods presented in the period of adoption or a modified retrospective approach. ASC 606 is effective for interim and annual periods beginning after December 15, 2016. Cynosure is currently evaluating the impact of the provisions of ASC 606.

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Summary of Stock-Based Compensation Expenses	'
	Total stock-based compensation expense was recorded to cost of revenues and operating expenses based upon the functional responsibilities of the individual holding the respective share-based payments, as follows:
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014			2013		2014		2013
		(In thousands)
	Cost of revenues	$	79		$	44	$	219	$	121
	Sales and marketing		519			260		1,481		761
	Research and development		270			133		757		424
	General and administrative		1,108			430		2,863		1,264
	Total stock-based compensation expense	$	1,976		$	867	$	5,320	$	2,570
Summary of Share-Based Compensation Arrangement Fair Value Assumptions	'
	The weighted average fair value of the options granted during the nine months ended September 30, 2014 and 2013 was $10.51 and $13.10, respectively, using the following assumptions:
		Nine Months Ended September 30,
		2014		2013
	Risk-free interest rate	1.44% - 1.80%		0.79% - 1.49%
	Expected dividend yield
	Expected term	4.6 years		4.8 years
	Expected volatility	43% - 44%		54% - 56%
	Estimated forfeiture rate	5%		5%

Inventories_Tables

Inventories (Tables)	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Inventories	'
	Inventory includes material, labor and overhead and consists of the following:
		September 30,		December 31,
		2014		2013 (recast)
		(in thousands)
	Raw materials	$	15,158	$	16,900
	Work in process		3,886		2,316
	Finished goods		39,990		31,035
		$	59,034	$	50,251

Fair_Value_Tables

Fair Value (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Measurement of Fair Value Hierarchy for Financial Assets	'
	The following table represents Cynosure’s fair value hierarchy for its financial assets (cash equivalents and marketable securities) measured at fair value as of September 30, 2014 (in thousands):
			Level 1		Level 2		Level 3	Total
	Money market funds (1)		$	887	$		$	$	887
	State and municipal bonds					48,720			48,720
	Treasuries and government agencies					8,498			8,498
	Corporate obligations and commercial paper					2,007			2,007
	Equity securities			17					17
	Total		$	904	$	59,225	$	$	60,129
	-1	Included in cash and cash equivalents at September 30, 2014.
	During the nine months ended September 30, 2014, there were no significant transfers in and out of Level 1 and Level 2. Cynosure did not have any Level 3 financial assets at September 30, 2014 or December 31, 2013.

Short_and_LongTerm_Marketable_1

Short and Long-Term Marketable Securities (Tables)	9 Months Ended
	Sep. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
Schedule of Marketable Securities	'
	As of September 30, 2014, Cynosure’s marketable securities consist of the following (in thousands):
		Market		Amortized		Unrealized		Unrealized
		Value		Cost		Gains		Losses
	Available-for-Sale Securities:
	Short-term marketable securities:
	State and municipal bonds	$	26,145	$	26,129	$	16	$
	Treasuries and government agencies		6,002		6,001		1
	Corporate obligations and commercial paper		2,007		2,005		2
	Equity securities		17		22				(5	)
	Total short-term marketable securities	$	34,171	$	34,157	$	19	$	(5	)
	Long-term marketable securities:
	State and municipal bonds	$	22,575	$	22,569	$	11	$	(5	)
	Treasuries and government agencies		2,496		2,500				(4	)
	Total long-term marketable securities	$	25,071	$	25,069	$	11	$	(9	)
	Total available-for-sale securities	$	59,242	$	59,226	$	30	$	(14	)
	Total marketable securities	$	59,242
	As of December 31, 2013, Cynosure’s marketable securities consist of the following (in thousands):
		Market		Amortized		Unrealized		Unrealized
		Value		Cost		Gains		Losses
	Available-for-Sale Securities:
	Cash equivalents:
	State and municipal bonds	$	793	$	793	$		$
	Total cash equivalents	$	793	$	793	$		$
	Short-term marketable securities:
	State and municipal bonds	$	10,552	$	10,551	$	1	$
	Treasuries and government agencies		15,028		15,018		10
	Corporate obligations and commercial paper		1,004		1,004
	Equity securities		49		8		41
	Total short-term marketable securities	$	26,633	$	26,581	$	52	$
	Long-term marketable securities:
	State and municipal bonds	$	6,788	$	6,787	$	1	$
	Corporate obligations and commercial paper		2,016		2,015		1
	Total long-term marketable securities	$	8,804	$	8,802	$	2	$
	Total available-for-sale securities	$	36,230	$	36,176	$	54	$
	Total marketable securities	$	35,437
Schedule of Available-for-Sale Debt Securities Mature	'
	As of September 30, 2014, Cynosure’s available-for-sale debt securities mature as follows (in thousands):
		Total		Maturities
				Less		One to		More
				Than		Five		than
				One		Years		Five
				Year				Years
	State and municipal bonds	$	48,720	$	26,145	$	22,575	$
	Treasuries and government agencies		8,498		6,002		2,496
	Corporate obligations and commercial paper		2,007		2,007
	Total available-for-sale debt securities	$	59,225	$	34,154	$	25,071	$

Acquisitions_Tables

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Estimated Fair Value of Net Assets Acquired	'
	The following table summarizes the estimated fair value as of September 5, 2014 of the net assets acquired (in thousands):
	Purchase price:
	Cash paid	$	13,235
	Total	$	13,235
	Assets (liabilities) acquired:
	Accounts receivable		2,147
	Inventory		4,419
	Prepaids and other assets		488
	Property and equipment		576
	Intangible assets		6,800
	Goodwill		5,886
	Accounts payable		(9	)
	Accrued expenses		(2,452	)
	Deferred revenue		(460	)
	Other noncurrent liability		(4,160	)
	Total	$	13,235
Pro-forma Condensed Consolidated Operating Results	'
	The following unaudited pro forma condensed consolidated operating results for the three and nine months ended September 30, 2014 and 2013 summarize the combined results of operations for Cynosure and Ellman.
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014		2013
		(In thousands)
	Revenue (unaudited)	$	75,433		$	66,868		$	222,746	$	171,019
	Pre-tax income (loss) (unaudited)	$	4,027		$	(1,428	)	$	10,326	$	(15,735	)

Goodwill_Tables

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Changes to Goodwill	'
	Changes to goodwill during the nine months ended September 30, 2014 were as follows (in thousands):
	Balance   December 31, 2013 (recast)	$	99,237
	Ellman acquisition		5,886
	Translation adjustment		(8	)
	Balance   September 30, 2014	$	105,115

Other_Intangible_Assets_Tables

Other Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Components of Other Intangible Assets	'
	Other intangible assets consist of the following at September 30, 2014 and December 31, 2013 (in thousands):
		Developed			Business			Customer			Trade			Other			Total
		Technology			Licenses			Relationships			Names
		& Patents
	September 30, 2014
	Cost	$	29,240		$	384		$	19,718		$	18,390		$	1,338		$	69,070
	Translation adjustment					41			5						3			49
	Accumulated amortization		(6,370	)		(255	)		(5,244	)		(1,379	)		(8	)		(13,256	)
	Balance, September 30, 2014	$	22,870		$	170		$	14,479		$	17,011		$	1,333		$	55,863
	December 31, 2013
	Cost	$	27,510		$	384		$	15,833		$	16,930		$	1,338		$	61,995
	Translation adjustment					40			26						4			70
	Accumulated amortization		(2,216	)		(239	)		(3,662	)		(761	)		(8	)		(6,886	)
	Balance, December 31, 2013	$	25,294		$	185		$	12,197		$	16,169		$	1,334		$	55,179
Schedule of Amortization Expenses on Intangible Assets	'
	As of September 30, 2014, amortization expense on existing intangible assets for the next five years and beyond is as follows (in thousands):
	Remainder of 2014	$	2,282
	2015		9,156
	2016		8,365
	2017		6,376
	2018		4,860
	2019 and thereafter		23,494
	Total	$	54,533

Warranty_Costs_Tables

Warranty Costs (Tables)	9 Months Ended
	Sep. 30, 2014
Guarantees [Abstract]	'
Schedule of Change in Product Warranty Accrual	'
	The following table provides the detail of the change in Cynosure’s product warranty accrual during the nine months ended September 30, 2014, which is a component of accrued expenses in the consolidated balance sheets (in thousands):
	Balance   December 31, 2013	$	6,651
	Warranty provision related to new sales		10,484
	Costs incurred		(9,979	)
	Balance   September 30, 2014	$	7,156

Segment_Information_Tables

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Total Revenue by Geographic Destination	'
	The following table represents total revenue by geographic destination:
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		2014			2013			2014		2013
		(in thousands)
	United States	$	39,734		$	30,906		$	100,404	$	71,340
	Europe		10,207			10,013			35,830		26,786
	Asia / Pacific		15,131			13,570			47,857		37,300
	Other		6,458			6,203			22,016		16,047
	Total	$	71,530		$	60,692		$	206,107	$	151,473
Schedule of Total Assets by Geographic Area	'
	Total assets by geographic area are as follows:
		September 30,			December 31,
		2014			2013
		(in thousands)
	United States	$	400,149		$	380,383
	Europe		23,017			21,741
	Asia / Pacific		17,889			16,437
	Eliminations		(5,382	)		(3,860	)
	Total	$	435,673		$	414,701
Schedule of Long-Lived Assets by Geographic Area	'
	Long-lived assets by geographic area are as follows:
		September 30,			December 31,
		2014			2013
		(in thousands)
	United States	$	32,353		$	24,120
	Europe		2,259			2,403
	Asia / Pacific		2,256			1,600
	Total	$	36,868		$	28,123

Net_Income_Loss_Per_Common_Sha1

Net Income (Loss) Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Reconciliation of Basic and Diluted Shares	'
	A reconciliation of basic and diluted shares is as follows (in thousands, except per share data):
		Three Months Ended					Nine Months Ended
		September 30,					September 30,
		2014		2013			2014		2013
	Net income (loss)	$	3,074	$	(1,281	)	$	8,338	$	(8,996	)
	Basic weighted average common shares outstanding		21,637		22,331			21,900		18,406
	Weighted average common equivalent shares		263					380
	Diluted weighted average common shares outstanding		21,900		22,331			22,280		18,406
	Basic net income (loss) per share	$	0.14	$	(0.06	)	$	0.38	$	(0.49	)
	Diluted net income (loss) per share	$	0.14	$	(0.06	)	$	0.37	$	(0.49	)

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Loss (Tables)	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Changes to Accumulated Other Comprehensive Loss	'
	Changes to accumulated other comprehensive loss during the nine months ended September 30, 2014 were as follows (in thousands):
		Unrealized			Translation			Accumulated
		Gain on			Adjustment			Other
		Marketable						Comprehensive
		Securities, net						Loss
		of taxes
	Balance   December 31, 2013	$	36		$	(1,535	)	$	(1,499	)
	Current period other comprehensive loss		(16	)		(1,249	)		(1,265	)
	Balance   September 30, 2014	$	20		$	(2,784	)	$	(2,764	)

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Operating Facility, Certain Equipment and Vehicles Under Operating Lease and Capital Lease Agreements with Payments	'
	Cynosure leases the buildings portion of its U.S. operating facility and certain equipment and vehicles under capital lease agreements with payments due through May 2027. Commitments under Cynosure’s lease arrangements are as follows (in thousands):
		Operating		Capital
		Leases		Leases
	Remainder of 2014	$	420	$	73
	2015		1,292		146
	2016		1,396		2,165
	2017		1,418		2,550
	2018		1,369		2,515
	2019 and thereafter		3,726		22,680
	Total minimum lease payments	$	9,621	$	30,129
	Less amount representing interest				(14,269	)
	Present value of obligations under capital leases			$	15,860
	Current portion of capital lease obligations				171
	Capital lease obligations, net of current portion			$	15,689
Summary of Fixed Contractual Cash Obligations	'
	Cynosure has summarized in the table below its fixed contractual cash obligations as of September 30, 2014.
		Total		Less Than			One to		Three to		More than
				One Year			Three Years		Five Years		Five Years
		(In thousands)
	Capital lease obligations, including interest	$	30,129	$	183		$	4,114	$	5,036	$	20,796
	Operating leases		9,621		1,389			2,782		2,064		3,386
	Total contractual obligations	$	39,750	$	1,572		$	6,896	$	7,100	$	24,182

StockBased_Compensation_Additi

Stock-Based Compensation - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Stock-based compensation expense	$1,976,000	$867,000	$5,320,000	$2,570,000
Stock-based compensation expense capitalized to inventory	'	'	25,000	20,000
Cash received from option exercises	'	'	$7,600,000	$2,600,000
Stock options granted	'	'	849,680	386,010
Weighted average fair value of the options granted	'	'	$10.51	$13.10
Dividend yield	'	'	0.00%	0.00%
Restricted Stock Units (RSUs) [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Granted restricted stock units to employees	'	'	44,840	'
Vested period	'	'	'3 years	'
Share based compensation period	'	'	'3 years	'
Restricted Stock Units (RSUs) [Member] | Non Employee Director [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Granted restricted stock units to employees	'	'	43,500	'
Vested period	'	'	'1 year	'
Share based compensation period	'	'	'1 year	'

StockBased_Compensation_Summar

Stock-Based Compensation - Summary of Stock-Based Compensation Expenses (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Total stock-based compensation expense	$1,976	$867	$5,320	$2,570
Cost of Revenues [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Total stock-based compensation expense	79	44	219	121
Sales and Marketing [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Total stock-based compensation expense	519	260	1,481	761
Research and Development [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Total stock-based compensation expense	270	133	757	424
General and Administrative [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Total stock-based compensation expense	$1,108	$430	$2,863	$1,264

StockBased_Compensation_Summar1

Stock-Based Compensation - Summary of Share-Based Compensation Arrangement Fair Value Assumptions (Detail)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'
Risk-free interest rate - minimum	1.44%	0.79%
Risk-free interest rate - maximum	1.80%	1.49%
Expected dividend yield	0.00%	0.00%
Expected term	'4 years 7 months 6 days	'4 years 9 months 18 days
Expected volatility - minimum	43.00%	54.00%
Expected volatility - maximum	44.00%	56.00%
Estimated forfeiture rate	5.00%	5.00%

Inventories_Inventories_Detail

Inventories - Inventories (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Raw materials	$15,158	$16,900
Work in process	3,886	2,316
Finished goods	39,990	31,035
Inventories, Total	$59,034	$50,251

Fair_Value_Measurement_of_Fair

Fair Value - Measurement of Fair Value Hierarchy for Financial Assets (Detail) (USD $)	Sep. 30, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	$60,129,000
Money Market Funds [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	887,000
State and Municipal Bonds [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	48,720,000
Treasuries and Government Agencies [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	8,498,000
Corporate Obligations and Commercial Paper [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	2,007,000
Equity Securities [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	17,000
Level 1 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	904,000
Level 1 [Member] | Money Market Funds [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	887,000
Level 1 [Member] | Equity Securities [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	17,000
Level 2 [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	59,225,000
Level 2 [Member] | State and Municipal Bonds [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	48,720,000
Level 2 [Member] | Treasuries and Government Agencies [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	8,498,000
Level 2 [Member] | Corporate Obligations and Commercial Paper [Member]	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'
Fair value of financial assets	$2,007,000

Fair_Value_Additional_Informat

Fair Value - Additional Information (Detail) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013
		Level 3 [Member]	Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'	'
Significant transfers in and out of Level 1 and Level 2	$0	'	'
Fair value of financial assets	$60,129,000	$0	$0

Short_and_LongTerm_Marketable_2

Short and Long-Term Marketable Securities - Additional Information (Detail) (USD $)	Sep. 30, 2014
Investments, Debt and Equity Securities [Abstract]	'
Available for sale securities in debt	$59,200,000
Available for sale securities in equity	$17,000

Short_and_LongTerm_Marketable_3

Short and Long-Term Marketable Securities - Schedule of Marketable Securities (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	$59,242	$36,230
Amortized Cost	59,226	36,176
Unrealized Gains	30	54
Unrealized Losses	-14	'
Total marketable securities	59,242	35,437
Cash Equivalents [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	'	793
Amortized Cost	'	793
Cash Equivalents [Member] | State and Municipal Bonds [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	'	793
Amortized Cost	'	793
Short-Term Marketable Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	34,171	26,633
Amortized Cost	34,157	26,581
Unrealized Gains	19	52
Unrealized Losses	-5	'
Short-Term Marketable Securities [Member] | Corporate Obligations and Commercial Paper [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	2,007	1,004
Amortized Cost	2,005	1,004
Unrealized Gains	2	'
Short-Term Marketable Securities [Member] | State and Municipal Bonds [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	26,145	10,552
Amortized Cost	26,129	10,551
Unrealized Gains	16	1
Short-Term Marketable Securities [Member] | Treasuries and Government Agencies [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	6,002	15,028
Amortized Cost	6,001	15,018
Unrealized Gains	1	10
Short-Term Marketable Securities [Member] | Equity Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	17	49
Amortized Cost	22	8
Unrealized Gains	'	41
Unrealized Losses	-5	'
Long-Term Marketable Securities [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	25,071	8,804
Amortized Cost	25,069	8,802
Unrealized Gains	11	2
Unrealized Losses	-9	'
Long-Term Marketable Securities [Member] | Corporate Obligations and Commercial Paper [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	'	2,016
Amortized Cost	'	2,015
Unrealized Gains	'	1
Long-Term Marketable Securities [Member] | State and Municipal Bonds [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	22,575	6,788
Amortized Cost	22,569	6,787
Unrealized Gains	11	1
Unrealized Losses	-5	'
Long-Term Marketable Securities [Member] | Treasuries and Government Agencies [Member]	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'
Market Value	2,496	'
Amortized Cost	2,500	'
Unrealized Losses	($4)	'

Short_and_LongTerm_Marketable_4

Short and Long-Term Marketable Securities - Schedule of Available-for-Sale Debt Securities Mature (Detail) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Schedule of Available-for-sale Securities [Line Items]	'
Total	$59,225
Less Than One Year	34,154
One to Five Years	25,071
Corporate Obligations and Commercial Paper [Member]	'
Schedule of Available-for-sale Securities [Line Items]	'
Total	2,007
Less Than One Year	2,007
State and Municipal Bonds [Member]	'
Schedule of Available-for-sale Securities [Line Items]	'
Total	48,720
Less Than One Year	26,145
One to Five Years	22,575
Treasuries and Government Agencies [Member]	'
Schedule of Available-for-sale Securities [Line Items]	'
Total	8,498
Less Than One Year	6,002
One to Five Years	$2,496

Acquisitions_Additional_Inform

Acquisitions - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended		0 Months Ended	9 Months Ended		0 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 05, 2014	Jun. 24, 2013	Sep. 30, 2014
					Ellman International, Inc. [Member]	Ellman International, Inc. [Member]	Ellman International, Inc. [Member]	Palomar Medical Technologies, Inc. [Member]	Palomar Medical Technologies, Inc. [Member]
Business Acquisition [Line Items]	'	'	'	'	'	'	'	'	'
Cash consideration	'	'	'	'	'	'	$13,200,000	'	'
Business acquisition effective date of acquisition	'	'	'	'	'	5-Sep-14	'	'	24-Jun-13
License transfer agreement purchase price	'	'	'	'	'	'	4,200,000	'	'
Revenue related to Ellman's operations	71,530,000	60,692,000	206,107,000	151,473,000	2,600,000	'	'	'	'
Amount associated with step up in fair value of finished goods inventory included in consolidated pro forma financial information	'	'	'	'	'	300,000	'	'	'
Decreased in inventory	'	'	'	'	'	'	'	3,800,000	'
Increase in deferred tax liability	'	'	'	'	'	'	'	200,000	'
Increase in accounts payable	'	'	'	'	'	'	'	100,000	'
Decrease in accrued expenses	'	'	'	'	'	'	'	$23,000	'

Acquisitions_Estimated_Fair_Va

Acquisitions - Estimated Fair Value of Net Assets Acquired (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Sep. 05, 2014	Sep. 05, 2014
In Thousands, unless otherwise specified			Ellman International, Inc. [Member]	Ellman International, Inc. [Member]
Business Acquisition [Line Items]	'	'	'	'
Cash paid	'	'	$13,235	'
Total	'	'	13,235	'
Assets (liabilities) acquired:	'	'	'	'
Accounts receivable	'	'	'	2,147
Inventory	'	'	'	4,419
Prepaids and other assets	'	'	'	488
Property and equipment	'	'	'	576
Intangible assets	'	'	'	6,800
Goodwill	105,115	99,237	'	5,886
Accounts payable	'	'	'	-9
Accrued expenses	'	'	'	-2,452
Deferred revenue	'	'	'	-460
Other noncurrent liability	'	'	'	-4,160
Total	'	'	'	$13,235

Acquisitions_Proforma_Condense

Acquisitions - Pro-forma Condensed Consolidated Operating Results (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Business Combinations [Abstract]	'	'	'	'
Revenue (unaudited)	$75,433	$66,868	$222,746	$171,019
Pre-tax income (loss) (unaudited)	$4,027	($1,428)	$10,326	($15,735)

Goodwill_Schedule_of_Changes_t

Goodwill - Schedule of Changes to Goodwill (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Balance December 31, 2013 (recast)	$99,237
Ellman acquisition	5,886
Translation adjustment	-8
Balance September 30, 2014	$105,115

Other_Intangible_Assets_Schedu

Other Intangible Assets - Schedule of Components of Other Intangible Assets (Detail) (USD $)	9 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	$69,070	$61,995
Translation adjustment	49	70
Accumulated amortization	-13,256	-6,886
Balance	55,863	55,179
Developed Technology and Patents [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	29,240	27,510
Accumulated amortization	-6,370	-2,216
Balance	22,870	25,294
Business Licenses [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	384	384
Translation adjustment	41	40
Accumulated amortization	-255	-239
Balance	170	185
Customer Relationships [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	19,718	15,833
Translation adjustment	5	26
Accumulated amortization	-5,244	-3,662
Balance	14,479	12,197
Trade Names [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	18,390	16,930
Accumulated amortization	-1,379	-761
Balance	17,011	16,169
Other Intangible Assets [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Cost	1,338	1,338
Translation adjustment	3	4
Accumulated amortization	-8	-8
Balance	$1,333	$1,334

Other_Intangible_Assets_Additi

Other Intangible Assets - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Amortization expense	$2,200,000	$1,400,000	$6,400,000	$2,100,000
Indefinite-life intangible assets	1,300,000	'	1,300,000	'
Ellman International, Inc. [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Identifiable intangible assets acquired	'	'	6,800,000	'
Period of amortized identifiable intangible assets	'	'	'13 years	'
Fair value of identifiable intangible assets acquired	'	'	6,800,000	'
Amortization expense	27,000	'	27,000	'
Ellman International, Inc. [Member] | Cost of Revenues [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Amortization expense	32,000	'	32,000	'
Ellman International, Inc. [Member] | Technology Patents [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Identifiable intangible assets acquired	'	'	1,700,000	'
Period of amortized identifiable intangible assets	'	'	'7 years	'
Ellman International, Inc. [Member] | Customer Relationships [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Identifiable intangible assets acquired	'	'	3,600,000	'
Ellman International, Inc. [Member] | Trademarks [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Identifiable intangible assets acquired	'	'	$1,500,000	'
Ellman International, Inc. [Member] | Customer Relationships And Trademarks [Member]	'	'	'	'
Finite-Lived Intangible Assets [Line Items]	'	'	'	'
Period of amortized identifiable intangible assets	'	'	'15 years	'

Other_Intangible_Assets_Schedu1

Other Intangible Assets - Schedule of Amortization Expenses on Intangible Assets (Detail) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Goodwill and Intangible Assets Disclosure [Abstract]	'
Remainder of 2014	$2,282
2015	9,156
2016	8,365
2017	6,376
2018	4,860
2019 and thereafter	23,494
Total	$54,533

Warranty_Costs_Additional_Info

Warranty Costs - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2014
Guarantees [Abstract]	'
Warranty on end-user sales	'1 year

Warranty_Costs_Schedule_of_Cha

Warranty Costs - Schedule of Change in Product Warranty Accrual (Detail) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014
Guarantees [Abstract]	'
Balance, beginning of period	$6,651
Warranty provision related to new sales	10,484
Costs incurred	-9,979
Balance, end of period	$7,156

Segment_Information_Additional

Segment Information - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2014
	Country
	Segment
Segment Reporting [Abstract]	'
Number of operating segments	1
Number of individual countries with greater than 10% of total revenue, total assets or total long lived assets	0
Percentage of total revenue	10.00%

Segment_Information_Schedule_o

Segment Information - Schedule of Total Revenue by Geographic Destination (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	$71,530	$60,692	$206,107	$151,473
United States [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	39,734	30,906	100,404	71,340
Europe [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	10,207	10,013	35,830	26,786
Asia / Pacific [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	15,131	13,570	47,857	37,300
Other Country [Member]	'	'	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'	'	'
Total revenue	$6,458	$6,203	$22,016	$16,047

Segment_Information_Schedule_o1

Segment Information - Schedule of Total Assets by Geographic Area (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Total assets	$435,673	$414,701
Operating Segments [Member] | United States [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Total assets	400,149	380,383
Operating Segments [Member] | Europe [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Total assets	23,017	21,741
Operating Segments [Member] | Asia / Pacific [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Total assets	17,889	16,437
Eliminations [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Total assets	($5,382)	($3,860)

Segment_Information_Schedule_o2

Segment Information - Schedule of Long-Lived Assets by Geographic Area (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Long-lived assets	$36,868	$28,123
United States [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Long-lived assets	32,353	24,120
Europe [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Long-lived assets	2,259	2,403
Asia / Pacific [Member]	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Long-lived assets	$2,256	$1,600

Net_Income_Loss_Per_Common_Sha2

Net Income (Loss) Per Common Share - Additional Information (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2013
	Stock Option [Member]	Stock Option [Member]	Stock Option [Member]	Restricted Stock Units (RSUs) [Member]	Common Stock Class B [Member]	Common Stock Class B [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]	'	'	'	'	'	'
Class B Common stock outstanding	'	'	'	'	0	0
Outstanding options to purchase (shares)	1,700,000	1,000,000	1,100,000	1,500,000	'	'

Net_Income_Loss_Per_Common_Sha3

Net Income (Loss) Per Common Share - Schedule of Reconciliation of Basic and Diluted Shares (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Earnings Per Share [Abstract]	'	'	'	'
Net income (loss)	$3,074	($1,281)	$8,338	($8,996)
Basic weighted average common shares outstanding	21,637	22,331	21,900	18,406
Weighted average common equivalent shares	263	'	380	'
Diluted weighted average common shares outstanding	21,900	22,331	22,280	18,406
Basic net income (loss) per share	$0.14	($0.06)	$0.38	($0.49)
Diluted net income (loss) per share	$0.14	($0.06)	$0.37	($0.49)

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss - Changes to Accumulated Other Comprehensive Loss (Detail) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Loss, Beginning Balance	'	'	($1,499)	'
Accumulated Other Comprehensive Loss, Current period other comprehensive loss	-1,441	724	-1,265	117
Accumulated Other Comprehensive Loss, Ending Balance	-2,764	'	-2,764	'
Unrealized Gain on Marketable Securities, Net of Taxes [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Loss, Beginning Balance	'	'	36	'
Accumulated Other Comprehensive Loss, Current period other comprehensive loss	'	'	-16	'
Accumulated Other Comprehensive Loss, Ending Balance	20	'	20	'
Translation Adjustment [Member]	'	'	'	'
Accumulated Other Comprehensive Income (Loss) [Line Items]	'	'	'	'
Accumulated Other Comprehensive Loss, Beginning Balance	'	'	-1,535	'
Accumulated Other Comprehensive Loss, Current period other comprehensive loss	'	'	-1,249	'
Accumulated Other Comprehensive Loss, Ending Balance	($2,784)	'	($2,784)	'

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'	'	'	'	'
Income tax provision	$1,007,000	$601,000	$3,074,000	($4,683,000)	'
Effective tax rate	25.00%	-88.00%	'	'	'
Unrecognized tax benefits	'	900,000	'	900,000	1,700,000
Unrecognized tax benefit if recognized would impact effective tax rate	'	100,000	'	100,000	100,000
Decrease in unrecognized tax benefits	'	'	$800,000	'	'

Commitments_and_Contingencies_1

Commitments and Contingencies - Additional Information (Detail) (USD $)	3 Months Ended	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'	'
Operating lease rent expense	$0.60	$2.50
Operating lease expiration period	'	'2027-05

Commitments_and_Contingencies_2

Commitments and Contingencies - Operating Facility, Certain Equipment and Vehicles Under Operating Lease and Capital Lease Agreements with Payments (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Commitments and Contingencies Disclosure [Abstract]	'	'
Remainder of 2014	$420	'
2015	1,292	'
2016	1,396	'
2017	1,418	'
2018	1,369	'
2019 and thereafter	3,726	'
Total minimum lease payments	9,621	'
Remainder of 2014	73	'
2015	146	'
2016	2,165	'
2017	2,550	'
2018	2,515	'
2019 and thereafter	22,680	'
Total minimum lease payments	30,129	'
Less amount representing interest	-14,269	'
Present value of obligations under capital leases	15,860	'
Current portion of capital lease obligations	171	286
Capital lease obligations, net of current portion	15,689	14,957
Present value of obligations under capital leases	$15,860	'

Commitments_and_Contingencies_3

Commitments and Contingencies - Summary of Fixed Contractual Cash Obligations (Detail) (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Contractual Obligation [Line Items]	'
Capital lease obligations, including interest	$30,129
Operating leases	9,621
Total contractual obligations	39,750
Less Than One Year [Member]	'
Contractual Obligation [Line Items]	'
Capital lease obligations, including interest	183
Operating leases	1,389
Total contractual obligations	1,572
One To Three Years [Member]	'
Contractual Obligation [Line Items]	'
Capital lease obligations, including interest	4,114
Operating leases	2,782
Total contractual obligations	6,896
Three To Five Years [Member]	'
Contractual Obligation [Line Items]	'
Capital lease obligations, including interest	5,036
Operating leases	2,064
Total contractual obligations	7,100
More Than Five Years [Member]	'
Contractual Obligation [Line Items]	'
Capital lease obligations, including interest	20,796
Operating leases	3,386
Total contractual obligations	$24,182